Literature DB >> 25122947

Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2015.

.   

Abstract

This final rule updates the prospective payment rates for inpatient rehabilitation facilities (IRFs) for federal fiscal year (FY) 2015 as required by the statute. This final rule finalizes a policy to collect data on the amount and mode (that is, Individual, Concurrent, Group, and Co-Treatment) of therapy provided in the IRF setting according to therapy discipline, revises the list of diagnosis and impairment group codes that presumptively meet the "60 percent rule'' compliance criteria, provides a way for IRFs to indicate on the Inpatient Rehabilitation Facility-Patient Assessment Instrument (IRF-PAI) form whether the prior treatment and severity requirements have been met for arthritis cases to presumptively meet the "60 percent rule'' compliance criteria, and revises and updates quality measures and reporting requirements under the IRF quality reporting program (QRP). This rule also delays the effective date for the revisions to the list of diagnosis codes that are used to determine presumptive compliance under the "60 percent rule'' that were finalized in FY 2014 IRF PPS final rule and adopts the revisions to the list of diagnosis codes that are used to determine presumptive compliance under the "60 percent rule'' that are finalized in this rule. This final rule also addresses the implementation of the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), for the IRF prospective payment system (PPS), which will be effective when ICD-10-CM becomes the required medical data code set for use on Medicare claims and IRF-PAI submissions.

Entities:  

Mesh:

Year:  2014        PMID: 25122947

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  8 in total

1.  Hospital Readmission Following Discharge From Inpatient Rehabilitation for Older Adults With Debility.

Authors:  Rebecca V Galloway; Amol M Karmarkar; James E Graham; Alai Tan; Mukaila Raji; Carl V Granger; Kenneth J Ottenbacher
Journal:  Phys Ther       Date:  2015-12-04

2.  Octogenarians' post-acute care use after cardiac valve surgery and recovery: clinical implications.

Authors:  Elizabeth Edmiston; Mary A Dolansky; Melissa Zullo; Daniel E Forman
Journal:  Geriatr Nurs       Date:  2017-12-21       Impact factor: 2.361

3.  Predictors of 30-Day Readmission Following Inpatient Rehabilitation for Patients at High Risk for Hospital Readmission.

Authors:  Steve R Fisher; James E Graham; Shilpa Krishnan; Kenneth J Ottenbacher
Journal:  Phys Ther       Date:  2015-09-10

4.  Predictors of readmission to acute care during inpatient rehabilitation for non-traumatic spinal cord injury.

Authors:  David M Robinson; Moussa S Bazzi; Scott R Millis; Ali A Bitar
Journal:  J Spinal Cord Med       Date:  2018-01-22       Impact factor: 1.985

5.  Swallowing Status Comparison between Primary Dysphagia and Post-stroke Dysphagia in Inpatient Rehabilitation Facilities.

Authors:  Ickpyo Hong; Kimberly P Hreha
Journal:  Swallowing Rehabil       Date:  2020-03

6.  An Examination of the First 30 Days After Patients are Discharged to the Community From Hip Fracture Postacute Care.

Authors:  Natalie E Leland; Pedro Gozalo; Thomas J Christian; Julie Bynum; Vince Mor; Terrie F Wetle; Joan M Teno
Journal:  Med Care       Date:  2015-10       Impact factor: 2.983

7.  Functional motor improvement during inpatient rehabilitation among older adults with traumatic brain injury.

Authors:  Emily Evans; Cicely Krebill; Roee Gutman; Linda Resnik; Mark R Zonfrillo; Stephanie N Lueckel; Wenhan Zhang; Raj G Kumar; Kristen Dams-O'Connor; Kali S Thomas
Journal:  PM R       Date:  2021-06-28       Impact factor: 2.218

8.  A Single-Center Cost Analysis of Treating Primary and Metastatic Brain Cancers with Either Brain Laser Interstitial Thermal Therapy (LITT) or Craniotomy.

Authors:  Eric C Leuthardt; Jeff Voigt; Albert H Kim; Pete Sylvester
Journal:  Pharmacoecon Open       Date:  2017-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.